Hotline: 098.679.8008



Trusted Company

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years. Since Bukwang was listed in the Korea Stock Exchange in 1988, Bukwang is proud to have kept a healthy financial status and stable track record that earned trust from its employees and shareholders. Bukwang’s operating profit is at the top of the rank in the industry, nearing 20% as of financial year 2014.
Bukwang’s armamentarium consists of more than 100 products in various therapeutic areas: liver disease treatments such as Levovir and Legalon, diabetic complication products such as Dexid and Thioctacid, CNS disorder drugs including Lonasen, Ixel and Orfil, and respiratory disease treatments such as Azeptin and Asima. Bukwang continues to grow its original drug business through consistent focus on new drug development.
Bukwang was designated as “Korea Innovative Pharmaceutical Company” by the Korean government. Bukwang developed Levovir (clevudine) as the 4th new drug for hepatitis B in the world and licensed out to countries in Asia. Also, the first GMP manufacturing facility in Korea was established by Bukwang, and a new GMP facility that meets global standards was built as well, which improved our productive competitive edge.
Bukwang is developing innovative new drug candidates in partnership with pharmaceutical and bio-venture companies in Korea and abroad. Bukwang is carrying out multinational clinical trial for an anti-diatetes compound together with Melior Pharmaceuticals in the US, and co-developing a targeted anti-cancer drug with LSK BioPartners in the US. Also, Bukwang licensed in a novel candidate for movement disorder in Parkinson’s disease patients from Contera Pharma in Denmark, which Bukwang acquired in 2014. Bukwang has an affiliated company called Anterogen, a Korean bio-venture company specializing in cell therapies using adult stem cells. In 2012, Bukwang participated in financing of EyeGene, a Korean bio-venture, and in 2015, invested in Acer Therapeutics, a rare disease specialist company in the US. In addition, Bukwang signed a strategic partnership with TVM Capital Life Science, a globally renown venture capital firm, and carried out investment in an American CRO through Medivate Partners, a leading healthcare investment firm in Korea. Bukwang will continue to invest in promising companies in Korea and abroad.
In addition to ethical drugs, Bukwang is expanding its consumer health division with OTC products, household goods (toothpastes, hair care, skin care) and nutritional supplements with the hope of improving the consumers’ health and quality of life.
Bukwang is focusing its investment on R&D and currently developing the following new drug candidates:
MLR-1023: insulin sensitizer in type 2 diabetes
JM-010: levodopa-induced dyskinesia in Parkinson’s disease patients
JM-012: morning akinesia in Parkinson’s disease patients
SOL-804: Prostate cancer treatment
Dyna Therapeutics: Drug research and development
Bukwang acquired 100% shares of Contera Pharma ApS in 2014, which is a bioventure company specializd in CNS area. We are establishing an R&D network with the Danish academia, laboratories, pharmas and bio-ventures.
Also, Bukwang has a subsidiary company Anterogen Co., Ltd., a Korean bioventure developing cell therapies using adult stem cells.
From Bukwang Website!




Cao sâm

sâm tẩm mật ong

bánh kẹo Hàn Quốc

viên nang mềm
viên đạm
sâm củ khô
xốt ướp
cao hắc sâm
hồng sâm trẻ em
hồng sâm baby

nấm linh chi

nấm linh chi đỏ
nấm linh chi vàng
nấm linh chi sừng hươu
nấm linh chi hoa
cao linh chi
rượu Hàn Quốc
rượu gạo Hàn Quốc
rượu sochu
rượu soju

nước hồng sâm

tinh chất sâm
tinh dầu thông đỏ
an cung ngưu hoàng hoàn
viên chống đột quỵ

bộ quà tặng

cao hồng sâm

nước hồng sâm trẻ em
viên hoàn hồng sâm
viên hoàn đông trùng hạ thảo

đông trùng hạ thảo

bổ gan
giải rượu
cao dán sâm Hàn Quốc
cao dán trị nhức mỏi
sâm củ tươi Hàn Quốc

sữa rửa mặt

gel rửa mặt

kem rửa mặt

bánh que LOTTE
viên uống hỗ trợ điều trị gút (gout)
kẹo sâm
kẹo sâm không đường
nước sâm có củ
tỏi đen
rễ sâm
nấm linh chi thượng hoàng
bổ sung canxi
cao đông trùng hạ thảo
tương ớt Hàn Quốc
tương đậu
giấm Hàn Quốc
tương cà chua
đường Hàn Quốc
bánh xếp Hàn Quốc
viên uống bổ sung omega
sâm tươi Hàn Quốc (nhân sâm)
chống say tàu xe
táo đỏ sấy khô
ớt bột Hàn Quốc
Lakota Canada
viên uống đặc trị đau nhức Lakota
nước uống tăng lực Hàn Quốc
mát gan - giải độc
cao sâm 2 hũ (cao hũ đôi)
nấm linh chi thái lát
cao hồng sâm Hoàng Hậu
cao hồng sâm Hoàng Đế
nước hồng sâm nhung hươu
dầu xoa bóp khớp
nước hồng sâm linh chi
tăng cường sinh lý
uống bổ sung collagen
nước hồng sâm baby

Số ĐKKD: 01M8013050 do UBND Q. Hoàng Mai, Hà Nội cấp ngày 20/01/2015
Fanpage: fb/hangnhapkhauaau.vn  * YN/Tweeter/Skype/Gmail: hangnhapkhauaau
Cơ sở 1: Số 119 A3 Khu Đô thị Đại Kim, Quận Hoàng Mai, TP Hà Nội    (Bản đồ)
Điện thoại: (04) 66.758.758 * 3681.4426 * 098 679 8008 - Fax: (04) 3681 4428 
Hotline: 098.679.8008 * 090.326.0123
Người đại diện-Chủ tài khoản: HÀ THỊ MINH PHƯƠNG
- STK: 0301000337007 - tại Vietcombank - Chi nhánh Hoàn Kiếm - Hà Nội.
- STK: 1482205148919 - tại Agribank -Chi nhánh Hùng Vương - Hà Nội.
- STK: 03501013927726 - tại Maritime Bank Định Công - Hà Nội.
- STK: 21310000417461 - tại BIDV - Chi nhánh Nam Hà Nội.



Thêm vào giỏ Mua ngay